ArticleCancer management and research2025
Predicting Axillary Lymph Node Metastasis in Breast Cancer Using Ultrasound and Machine Learning with SHAP.
Article in Cancer management and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multicenter Validation of an Integrated DCE-MRI Radiomics, Deep Learning, and S-II Model for Predicting Axillary Lymph Node Metastasis in Breast Cancer.Journal of multidisciplinary healthcare · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurate preoperative prediction of axillary lymph node (ALN) metastasis in breast cancer is crucial for surgical planning and reducing morbidity. Conventional ultrasound and Doppler methods are limited by subjectivity, while existing machine learning (ML) models often lack interpretability and multi-center validation. Aim: To evaluate 11 ML algorithms and develop a validated model integrating ultrasound and Doppler features for ALN metastasis prediction, using SHapley Additive exPlanations (SHAP) for interpretability. Methods: This retrospective dual-center study included 303 patients from Xiamen (internal cohorts: 212 training, 91 validation) and 102 from Longyan (external validation). Features were extracted from preoperative ultrasound and Doppler images. Recursive feature elimination (RFE) and SHAP selected key predictors. Gradient Boosting was identified as optimal and compared to B-mode/Doppler submodels and clinicopathological scores (Logical, Tumor, Tenon). Performance was assessed via AUC, calibration, decision curve analysis (DCA), and a web calculator was developed. Results: Five features-tumor diameter, cortex-to-hilum ratio, lymph node systolic/diastolic ratio, peak systolic velocity, and end-diastolic velocity-were selected. The combined model achieved AUCs of 0.981 (training), 0.975 (internal validation), and 0.987 (external validation), outperforming scores (AUCs 0.517-0.700). It showed superior calibration (Brier scores 0.045-0.061) and net benefit in DCA. Conclusion: The Gradient Boosting model with SHAP provides accurate, interpretable ALN metastasis prediction, supporting noninvasive risk stratification and personalized breast cancer management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.